Artemis Global Life Sciences announcements, page 2

Jan 2019

21 Jan · Intimation Of Publication Of Notice
In pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith a copy of notice published in the following newspapers:- .... (opens in a new tab)
21 Jan · Updates
Intimation of Publication of Notice \ (opens in a new tab)
21 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
21 Jan · Board meeting
Meeting of the Board of Directors of the Company is scheduled on 04/02/2019 ,inter alia, to consider and approve Dear Sir/ Madam, .... (opens in a new tab)
21 Jan · Board meeting
To consider and approve the financial results for the period ended December 31, 2018 and other business mattersDear Sir/ Madam,We, Artemis Global Life Sciences Limited ( Company) wish to inform you that, pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on February 4, 2019 (Monday), inter alia, to consider and approve unaudited financial results (standalone & consolidated) of the Company for the quarter ended December 31, 2018.Further the Company confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons that shall commence from 6:00 P.M. on January 21, 2019 and will end 48 hours after the results are made public on February 4, 2019.This is for your information and records. (opens in a new tab)
14 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
7 Jan · Meeting
Copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
6 Jan · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
5 Jan · Results
Please find enclosed with following:- 1. Details of Voting results (Including E-Voting & Physical Ballot) of the resolution mentioned in the Postal Ballot Notice dated 27th November, .... (opens in a new tab)

Dec 2018

26 Dec · Business
Copies of the notice to equity shareholder of Artemis Global Life Sciences Ltd. and notice to secured & unsecured creditor of Artemis Medicare Services Ltd. published in newspapers. (opens in a new tab)
26 Dec · Sub:Intimation Of Publication Of Notice
Sub:Intimation of Publication of Notice REF: COMPOSITE SCHEME OF AMALGAMATION BETWEEN ARTEMIS GLOBAL LIFE SCIENCES LIMITED ('COMPANY'), ARTEMIS HEALTH SCIENCES LIMITED ('AHSL'), .... (opens in a new tab)
24 Dec · Business
Disclosure pursuant to Regulation 11, 30 and 37 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (opens in a new tab)
24 Dec · Disclosure Pursuant To Regulation 11, 30 And 37 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Sub: Disclosure pursuant to Regulation 11, 30 and 37 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 REF: COMPOSITE SCHEME OF AMALGAMATION BETWEEN ARTEMIS .... (opens in a new tab)
20 Dec · Business
Dislcosure pursuant to Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulation,2015. (opens in a new tab)
20 Dec · Announcement under Regulation 30 (LODR)-Restructuring
Sub: Disclosure pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 REF: COMPOSITE SCHEME OF AMALGAMATION BETWEEN ARTEMIS GLOBAL .... (opens in a new tab)
4 Dec · Meeting
Dear Sir/ Madam, In pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith a copy of notice published .... (opens in a new tab)
4 Dec · Updates
'Intimation of Publication of Postal Ballot Notice/Remote E-Voting '.Dear Sir/ Madam,In pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith a copy of notice published in the following newspapers:-- Business Standard (Naitonal daily newspaper) on December 3, 2018.- Business Standard (Daily newspaper of the State) on December 3, 2018Submitted for your information and records. (opens in a new tab)

Nov 2018

Oct 2018

29 Oct · Board meeting
Meeting of the Board of Directors of the Company is scheduled on 12/11/2018 ,inter alia, to consider and approve Dear Sir/ Madam, .... (opens in a new tab)
29 Oct · Board meeting
To consider and approve the financial results for the period ended September 30, 2018 and other business mattersSub: Notice of Board Meeting for approval of unaudited financial results for the quarter and half year ended September 30, 2018/Window Closure Notice Dear Sir/ Madam,We, Artemis Global Life Sciences Limited ( Company) wish to inform you that, pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 a meeting of the Board of Directors of the Company is scheduled to be held on 12th November, 2018, inter alia, to consider and approve unaudited financial results (standalone & consolidated) of the Company for the quarter and half year ended September 30, 2018.Further the Company confirms that as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company would remain closed for the concerned persons that shall commence from 6:00 P.M. on October 29, 2018 and will end 48 hours after the results are made public on November 12, 2018.This is for your information and records. (opens in a new tab)
18 Oct · Compliance Certificate
Sub: Compliance Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') . Dear Sir/ Madam, .... (opens in a new tab)
17 Oct · Shareholding for the Period Ended September 30, 2018
Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
16 Oct · Compliance Certificate For The Period Ended September 30, 2018
Dear Sir/ Madam, In Accordance with Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing herewith .... (opens in a new tab)
16 Oct · Compliance Certificate For The Period Ended September 30, 2018
Sub: Compliance Certificate under Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') . Dear Sir/ Madam, .... (opens in a new tab)
16 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0

Sep 2018

Aug 2018

Jul 2018

18 Jul · Board Meeting On August 3, 2018
Dear Sir/ Madam, We, Artemis Global Life Sciences Limited ('Company') wish to inform you that, pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board .... (opens in a new tab)
18 Jul · Board meeting
To consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended Jun 30, 2018. (opens in a new tab)
13 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0

May 2018

29 May · Updates
Ref: Submission of financial resultsSub:Regulation 33(3)(b)(i) of SEBI (LODR) Regulation, 2015Dear Sir/ Madam,Pursuant to the Regulation 33(3)(b)(i) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Company has opted to additionally submit quarterly/year to date consolidated financial results in the first quarter of the financial year 2018-19 and this option will not be changed during the said financial year.This is for your information and records.Thanking youYours Faithfully (opens in a new tab)

Artemis Global Life Sciences (Delisted) share news and announcements

Artemis Global Life Sciences share news and announcements

Jan 2019

Dec 2018

Nov 2018

Oct 2018

Sep 2018

Aug 2018

Jul 2018

May 2018